Powder: | Yes |
---|---|
Customized: | Customized |
Certification: | GMP, HSE, ISO 9001, USP, BP |
Suitable for: | Elderly, Adult |
State: | Solid |
Purity: | >96% |
Samples: |
---|
Customization: |
---|
Suppliers with verified business licenses
Product Name
|
Factory Price Fevipiprant/Qaw039 Powder CAS156223-05-1 |
Appearance
|
White to off-White Powder |
Assay
|
99%min, 98.0% --101.0% |
Test
|
HPLC
|
Certificate
|
ISO 9001
|
CAS
|
156223-05-1 |
MF | C19h20n2o2 |
Storage Temperature |
Cool Dry Place
|
However, following the discovery in 2012 that the prostaglandin D2 receptor (DP/PGD2) is expressed at high
levels in the scalp of men affected by male pattern baldness, the rights to setipiprant were acquired by Kythera
with a view to potentially developing this drug as a novel treatment for baldness, with a previously unexploited
mechanism of action. While it is too early to tell whether setipiprant will be an effective treatment for this condition,
the favorable pharmacokinetics and relative lack of side effects seen in earlier clinical trials mean that fresh
clinical trials for this new application can be conducted fairly quickly.
Suppliers with verified business licenses